Girardi G, Elías M M
Facultad de Ciencias Bioquimicas y Farmacéuticas, Rosario, República Argentina.
Arch Toxicol. 1995;69(9):603-7. doi: 10.1007/s002040050220.
The present study was undertaken to investigate if the source of oxidative stress and the renal injury produced by mercuric chloride could be renal ischaemia. Verapamil Vp was used because it was described that calcium channel blockers protect cells from nephrotoxicants and from ischaemia. Vp (75 micrograms/kg, i.v.; 30 min before HgCl2 injection) prevented mercuric chloride renal injury observed 1 h post-HgCl2 injection as measured by clearance techniques. Vp also prevented the diminution of non-protein-sulfhydryls (NPSH) and the increased lipid peroxidation (LPO) induced by HgCl2 in renal tissue. Hg2+ toxicokinetic alterations were not observed in Vp plus HgCl2 treated rats, nor was Vp ability found as a free radical scavenger in renal tissue homogenates. The results described in this study give some evidence for the role of renal ischaemia in the production of oxidative stress, generating LPO and functional and morphological renal injury described in mercuric chloride treated rats.
本研究旨在探究氯化汞产生的氧化应激源及肾损伤是否可能是肾缺血。使用维拉帕米(Vp)是因为有描述称钙通道阻滞剂可保护细胞免受肾毒物和缺血的影响。Vp(75微克/千克,静脉注射;在注射HgCl2前30分钟)可预防注射HgCl2 1小时后通过清除技术测量的氯化汞肾损伤。Vp还可预防肾组织中由HgCl2诱导的非蛋白巯基(NPSH)减少和脂质过氧化(LPO)增加。在Vp加HgCl2处理的大鼠中未观察到Hg2+毒代动力学改变,在肾组织匀浆中也未发现Vp具有自由基清除剂的能力。本研究中描述的结果为肾缺血在氧化应激产生中的作用提供了一些证据,氧化应激会产生LPO以及在氯化汞处理的大鼠中出现的功能性和形态学肾损伤。